Help Patients With Skyrocketing Insulin Costs

One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.

In the U.S., only 3 companies make insulin...driving up prices.

You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote